Nastia Hidayati

PT Kimia Farma Tbk, Indonesia

Poster(s):

• (243) Evaluation of Remifentanil's Safety Profile: A Multicenter Post Marketing Surveillance in Indonesia
  Sunday, August 28, 2022

  8:00 AM – 1:45 PM CEST

• (177) Post-Marketing Safety Profile of Pethidine in Indonesia
  Friday, August 26, 2022

  8:00 AM – 6:00 PM CEST